share_log

Equillium | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)

Equillium | SC 13G: Statement of acquisition of beneficial ownership by individuals-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)

Equillium | SC 13G:超過5%持股股東披露文件-Takeda Pharmaceutical Company Limited(5.2%),Takeda Ventures, Inc(5.2%)
美股SEC公告 ·  01/19 00:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息